Cytiva is expanding its Xcellerex X-platform portfolio with the addition of 500L and 2,000L bioreactors.

Ludovic Brellier, President of Hardware Solutions, Cytiva, said: “Our customers need speed and flexibility to develop advanced therapeutics. The expansion of Cytiva’s Xcellerex X-platform portfolio and its additional features will help our customers scale their operations more efficiently. The design and functionality of the hardware, biocontainers, and software will allow our customers to safely manufacture life-changing therapeutics faster.”

About the X-Platform

The X-platform bioreactor portfolio was designed to meet the process needs of early-stage clinical researchers all the way through to commercial manufacturing. Customers can easily scale from 50L to 2,000L while also reducing the time spent optimizing.

Additional features include: 

• An infrared-based camera that provides accurate detection of foam appearing in the process, allowing for early, automated intervention. 
• Working height management of exhaust filters and heaters designed to simplify filter changes and minimize the need for manipulations at height. 
• Quick and easy “off-the-shelf” bag configuration and installation which helps reduce the risk of error.